Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1080707

COc1c(C(=O)NCCCN2CCN(C)CC2)sc2c1c(=O)n(Cc1ccccn1)c1ccccc21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ HPGD P15428 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ TP53 P04637 5/20 0.44
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ DRD3 P35462 1/20 0.39
▸ THRB P10828 1/20 0.38
▸ AVPR1B P47901 1/20 0.38
▸ PARP1 P09874 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10314329 0.95 MAPT (0.49) MAPTKDM4EALDH1A1KMT2AHSD17B10
Trifluoroacetic Acid SCHEMBL1062144 0.93 KDM4E (0.45) MAPTKDM4EALDH1A1KMT2AHSD17B10
Trifluoroacetic Acid SCHEMBL1062006 0.90 KDM4E (0.43) MAPTKDM4EALDH1A1KMT2AHSD17B10
Trifluoroacetic Acid SCHEMBL1063790 0.89 RAB9A (0.44) MAPTKDM4EALDH1A1KMT2AHSD17B10
Trifluoroacetic Acid SCHEMBL1060742 0.88 L3MBTL1 (0.41) KDM4EALDH1A1KMT2ASMN1; SMN2TP53
SCHEMBL10314326 0.88 KDM4E (0.47) KDM4EALDH1A1KMT2AHSD17B10HPGD
Trifluoroacetic Acid SCHEMBL1062441 0.88 KMT2A (0.46) MAPTKDM4EALDH1A1KMT2AMAPK1
Trifluoroacetic Acid SCHEMBL1060516 0.87 ALDH1A1 (0.46) MAPTKDM4EALDH1A1KMT2AHSD17B10
Trifluoroacetic Acid SCHEMBL1061583 0.87 ALDH1A1 (0.48) MAPTKDM4EALDH1A1KMT2AHSD17B10
Trifluoroacetic Acid SCHEMBL1059829 0.87 RXFP1 (0.42) MAPTKDM4EALDH1A1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2247588-B1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2016-04-13 — — EP disclosed
US-8399449-B2 Fused heterocyclic derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-03-19 — — US disclosed
US-8217176-B2 Fused heterocyclic derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-07-10 — — US disclosed
US-20110003788-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-06 — — US disclosed
US-20090227561-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003788-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF SMO, NR1H2, NR1H4 MAPT 4789/4885KDM4E 528/4885ALDH1A1 745/4885
US-20090227561-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF SMO, NR1H2, NR1H4 MAPT 4727/4885KDM4E 464/4885ALDH1A1 776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback